Baseline characteristics | Transitioned cohort* (N=214) |
Sex | |
Female | 116/214 (54.2%) |
Male | 98/214 (45.8%) |
Race | |
Black or African American | 45/213 (21.1%) |
Caucasian/white | 155/213 (72.8%) |
Two or more races | 6/213 (2.8%) |
Other | 7/213 (3.3%) |
Ethnicity | |
Hispanic | 7/214 (3.3%) |
Not Hispanic | 203/214 (94.9%) |
Not reported | 4/214 (1.9%) |
Last pediatric encounter payor | |
Commercial health insurance | 20/203 (9.9%) |
Medicaid | 176/203 (86.7%) |
Medicare | 5/203 (2.5%) |
Other | 2/203 (1.0%) |
Comorbidities | |
Depression diagnosis | 31/214 (14.5%) |
Anxiety diagnosis | 9/214 (4.2%) |
Hypertension diagnosis | 15/214 (7.0%) |
Hyperlipidemia diagnosis | 30/214 (14.0%) |
Obesity diagnosis | 20/214 (9.3%) |
Last pediatric A1c value: N, median (25th–75th), mean (min–max) | 200, 8.25 (7.20–9.85), 8.73 (5.00–15.10) |
Average number of pediatric endocrinology visits per year: N, median (25th–75th), mean (min–max) | 214, 2.51 (2.14–3.01), 2.58 (0.00–10.33) |
Average number of hospital admissions per year: N, median (25th–75th), mean (min–max) | 214, 0.11 (0.00–0.37), 0.49 (0.00–17.87) |
Average number of ED visits per year: N, median (25th–75th), mean (min–max) | 214, 0.08 (0.00–0.35), 0.51 (0.00–14.30) |
*Cohort was those who had at least two pediatric endocrinology encounters and one adult endocrinology encounter at Duke. Participants who took longer than 36 months to transfer to adult care were excluded from the analysis.
ED, emergency department.